Results 261 to 270 of about 414,010 (359)

Toll-Like Receptor Signaling in Liver Diseases

Gastroenterology Research and Practice, 2010
Gyongyi Szabo, Timothy R. Billiar, Keigo Machida, Ian Nicholas Crispe, Ekihiro Seki   +4 more
doaj   +1 more source

Activation of chicken macrophages by isomalto/malto-polysaccharide (IMMP) is facilitated by toll-like receptor 4 (TLR4). [PDF]

Poult Sci
Ijaz A, Putman M, Broere F, Rutten VPMG, Jansen CA, Veldhuizen EJA.   +5 more
europepmc   +1 more source

Back Again to the Future: A New Era for Cerebroprotection

Annals of Neurology, EarlyView.
Cerebroprotection is a fresh framework for designing neurological therapy that targets glia and vascular cells, in addition to neurons. In the future, successful cerebroprotection will involve targeting all elements of the neurovascular unit. Preclinical trials must include functional outcomes, as well as lesion morphometry.
Patrick Lyden
wiley   +1 more source

Small Intestine Neuromuscular Dysfunctions and Neurogliopathy in a Mouse Model of High-Fat Diet-Induced Obesity: Involvement of Toll-Like Receptor 4. [PDF]

Int J Mol Sci
Faggin S, Cerantola S, Bosi A, Giaroni C, Napoli E, Savarino EV, Contran M, Porzionato A, Pellegrini C, Antonioli L, Caputi V, Giron MC.   +11 more
europepmc   +1 more source

Increased expression of Toll-like receptors 2, 3, 4 and 7 mRNA in the kidney and intestine of a septic mouse model

, 2019
Sylvia Krivan, Alkistis Kapelouzou, Stylianos Vagios, Diamantis I. Tsilimigras, Michalis Katsimpoulas, Dimitrios Moris, Chrysostomos V. Aravanis, Theano Demesticha, Dimitriοs Schizas, Manolis Mavroidis, Kitty Pavlakis, Nikolaos Machairas, Evangelos Misiakos, Theodore Liakakos   +13 more
openalex   +1 more source

Metabolism‐Regulating Nanomedicines for Cancer Therapy

Advanced NanoBiomed Research, EarlyView.
This review highlights metabolism‐regulating nanomedicines designed to target glycolytic, lipid, amino acid, and nucleotide pathways in tumors. By incorporating metabolism‐regulating agents into versatile nanocarriers such as liposomes, micelles, dendrimers, and engineered bacteria, these platforms achieve targeted delivery, controlled release ...
Xiao Wu, Shiyi Geng, Jian Yang
wiley   +1 more source

Expression of Concern: The IkappaB Kinase Family Phosphorylates the Parkinson's Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

TLR10: An intriguing Toll-like receptor with many unanswered questions

Carolina Rego Rodrigues, Yadu Balachandran, Gurpreet Kaur Aulakh, Baljit Singh   +3 more
openalex   +1 more source

Engineering Ultrasound Contrast Agents for Targeted Therapeutics: A Theranostic Approach to Drug Delivery, Gene Therapy, and Immunomodulation

Advanced NanoBiomed Research, EarlyView.
Ultrasound contrast agents, including microbubbles and nanobubbles, transform imaging and targeted therapy through precise engineering of size, shell composition, and surface properties. This review explores how these innovations enable tissue‐specific delivery, enhance therapeutic efficacy, and extend applications from vascular imaging to tumor ...
Ashkan Seza, Kimia Mozahheb Yousefi, Sara Minaeian   +2 more
wiley   +1 more source

Toll-Like Receptor Polymorphisms Influence Graft-Versus-Host Disease and Infection Risk After Single-Unit Cord Blood Transplantation for Adults. [PDF]

Eur J Haematol
Konuma T, Hamatani-Asakura M, Kato S, Andoh S, Ichimura H, Kuroda J, Kondo K, Yokoyama K, Monna-Oiwa M, Nannya Y, Takahashi S.   +10 more
europepmc   +1 more source